MedDataX Logo

Role of Skin Tests for the Diagnosis of Immediate Hypersensitivity Reactions Due to Iodinated Contrast Media

NCT ID: NCT00819494

Last Updated: 2010-11-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

63 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-11-30

Study Completion Date

2009-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this trial is to study the diagnostic role of skin test in immediate reactions to iodinated radiocontrast media.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hypersensitivity

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Contrast media skin test Skin test hypersensitivity contrast media

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Healthy controls

Group Type SHAM_COMPARATOR

Skin tests with radiocontrast media

Intervention Type PROCEDURE

Skin prick tests and intradermal test will be performed in patients with a history of immediate reactions to iodinated radiocontrast media

Patients with immediate reactions

Group Type ACTIVE_COMPARATOR

Skin tests with radiocontrast media

Intervention Type PROCEDURE

Skin prick tests and intradermal test will be performed in patients with a history of immediate reactions to iodinated radiocontrast media

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Skin tests with radiocontrast media

Skin prick tests and intradermal test will be performed in patients with a history of immediate reactions to iodinated radiocontrast media

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patients with history of immediate hypersensitivity reactions to iodinated contrast media
2. 15-70 years of age

Exclusion Criteria

1. On antihistamine/ cannot discontinue antihistamine before the test
2. Having asthma exacerbation
3. Being pregnant
4. Suffering from severe systemic disease/ in bad health
Minimum Eligible Age

15 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chulalongkorn University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Chulalongkorn University

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kiat Ruxrungtham, MD

Role: PRINCIPAL_INVESTIGATOR

Chulalongkorn University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of Medicine, Chulalongkorn University

Bangkok, , Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Chula-ARC 003/08

Identifier Type: -

Identifier Source: org_study_id